OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

IRF4 Activity Is Required in Established Plasma Cells to Regulate Gene Transcription and Mitochondrial Homeostasis
Michael Löw, Erica J. Brodie, Pasquale L. Fedele, et al.
Cell Reports (2019) Vol. 29, Iss. 9, pp. 2634-2645.e5
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Intrinsically determined turnover underlies broad heterogeneity in plasma-cell lifespan
M. Robinson, Zhoujie Ding, Mark R. Dowling, et al.
Immunity (2023) Vol. 56, Iss. 7, pp. 1596-1612.e4
Closed Access | Times Cited: 48

Altered function and differentiation of age-associated B cells contribute to the female bias in lupus mice
Edd Ricker, Michela Manni, Danny Flores-Castro, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 79

Crosstalk between endoplasmic reticulum stress and oxidative stress: a dynamic duo in multiple myeloma
Sinan Xiong, Wee Joo Chng, Jianbiao Zhou
Cellular and Molecular Life Sciences (2021) Vol. 78, Iss. 8, pp. 3883-3906
Open Access | Times Cited: 58

Mitochondrial respiration in B lymphocytes is essential for humoral immunity by controlling the flux of the TCA cycle
Sophia Urbanczyk, Olivier R. Baris, Jörg Hofmann, et al.
Cell Reports (2022) Vol. 39, Iss. 10, pp. 110912-110912
Open Access | Times Cited: 47

Mechanisms for resistance to BCMA-targeted immunotherapies in multiple myeloma
Tingting Yue, Yue Sun, Yun Dai, et al.
Blood Reviews (2025), pp. 101256-101256
Closed Access | Times Cited: 1

Selective antisense oligonucleotide inhibition of human IRF4 prevents malignant myeloma regeneration via cell cycle disruption
Phoebe Mondala, Ashni A. Vora, Tianyuan Zhou, et al.
Cell stem cell (2021) Vol. 28, Iss. 4, pp. 623-636.e9
Open Access | Times Cited: 47

How intrinsic and extrinsic regulators of plasma cell survival might intersect for durable humoral immunity
M. Robinson, Rosela H. Webster, David M. Tarlinton
Immunological Reviews (2020) Vol. 296, Iss. 1, pp. 87-103
Closed Access | Times Cited: 45

Chronic calcium signaling in IgE+ B cells limits plasma cell differentiation and survival
Rebecca Newman, Pavel Tolar
Immunity (2021) Vol. 54, Iss. 12, pp. 2756-2771.e10
Open Access | Times Cited: 37

Plasma cell survival: The intrinsic drivers, migratory signals, and extrinsic regulators
Doan C. Nguyen, Meixue Duan, Mohammad Ali, et al.
Immunological Reviews (2021) Vol. 303, Iss. 1, pp. 138-153
Open Access | Times Cited: 36

Plasmablast‐like Phenotype Among Antigen‐Experienced CXCR5CD19low B Cells in Systemic Lupus Erythematosus
Franziska Szelinski, Ana‐Luisa Stefanski, Eva Schrezenmeier, et al.
Arthritis & Rheumatology (2022) Vol. 74, Iss. 9, pp. 1556-1568
Open Access | Times Cited: 26

IgE plasma cells are transcriptionally and functionally distinct from other isotypes
Andrea Vecchione, Joseph C. Devlin, Carley Tasker, et al.
Science Immunology (2024) Vol. 9, Iss. 99
Open Access | Times Cited: 5

Interleukin-2-secreting T helper cells promote extra-follicular B cell maturation via intrinsic regulation of a B cell mTOR-AKT-Blimp-1 axis
Caterina E. Faliti, Maria Mesina, Jinyong Choi, et al.
Immunity (2024)
Closed Access | Times Cited: 4

Suppression of NF-κB and downstream XBP1 by DcR3 contributes to a decrease in antibody secretion
Po-Chun Liu, S. Huang, Kuo‐I Lin, et al.
The Journal of Immunology (2025) Vol. 214, Iss. 1, pp. 72-84
Closed Access

Distinct plasmablast developmental intermediates produce graded expression of IgM secretory transcripts
Evelyn Sievert, Marissa C. Franke, Kayla Thomas, et al.
Cell Reports (2025) Vol. 44, Iss. 2, pp. 115283-115283
Open Access

Interferon regulatory factor 4 mediates nonenzymatic IRE1 dependency in multiple myeloma cells
Ioanna Oikonomidi, Vasumathi Kameswaran, Victoria C. Pham, et al.
PLoS Biology (2025) Vol. 23, Iss. 4, pp. e3003096-e3003096
Open Access

Keeping up with the stress of antibody production: BAFF and APRIL maintain memory plasma cells
Rebecca Cornelis, Hyun‐Dong Chang, Andreas Radbruch
Current Opinion in Immunology (2021) Vol. 71, pp. 97-102
Closed Access | Times Cited: 26

The gene regulatory network controlling plasma cell function
Stephanie Trezise, Stephen L. Nutt
Immunological Reviews (2021) Vol. 303, Iss. 1, pp. 23-34
Open Access | Times Cited: 25

Abnormalities of bone marrow B cells and plasma cells in primary immune thrombocytopenia
Tianshu Yu, Haoyi Wang, Yajing Zhao, et al.
Blood Advances (2021) Vol. 5, Iss. 20, pp. 4087-4101
Open Access | Times Cited: 24

Analysis of the heterogeneity and complexity of murine extraorbital lacrimal gland via single-cell RNA sequencing
Duliurui Huang, Xinwei Jiao, Shenzhen Huang, et al.
The Ocular Surface (2024) Vol. 34, pp. 60-95
Open Access | Times Cited: 3

Decoding plasma cell maturation dynamics with BCMA
Sebastian Schulz, Stephan Menzel, Jens Wittner, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

Overexpression of transcription factor BLIMP1/prdm1 leads to growth inhibition and enhanced secretory capacity in Chinese hamster ovary cells
Mauro Torres, Alan J. Dickson
Metabolic Engineering (2021) Vol. 67, pp. 237-249
Closed Access | Times Cited: 21

Generation of a CRISPR activation mouse that enables modelling of aggressive lymphoma and interrogation of venetoclax resistance
Yexuan Deng, Sarah T. Diepstraten, Margaret A. Potts, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 16

Targeting plasma cells in systemic autoimmune rheumatic diseases – Promises and pitfalls
Tobit Steinmetz, Gwenny M. Verstappen, Jolien Suurmond, et al.
Immunology Letters (2023) Vol. 260, pp. 44-57
Open Access | Times Cited: 9

Mechanisms of Action of the New Antibodies in Use in Multiple Myeloma
Alessandra Romano, Paola Storti, Valentina Marchica, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 18

The deubiquitinase OTUD1 regulates immunoglobulin production and proteasome inhibitor sensitivity in multiple myeloma
Alexander Vdovin, Tomáš Jelı́nek, David Žihala, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 14

Page 1 - Next Page

Scroll to top